End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | +50.00% | -.--% | -.--% |
Valuation
Fiscal Period: December | 2022 |
---|---|
Capitalization 1 | 0.4665 |
Enterprise Value (EV) 1 | 0.2301 |
P/E ratio | -0.15 x |
Yield | - |
Capitalization / Revenue | 0.39 x |
EV / Revenue | 0.19 x |
EV / EBITDA | -0.08 x |
EV / FCF | -147,663 x |
FCF Yield | -0% |
Price to Book | 1.17 x |
Nbr of stocks (in thousands) | 63,250 |
Reference price 2 | 0.007375 |
Announcement Date | 3/31/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales 1 | 0.8021 | 0.9778 | 1.141 | 1.119 | 1.203 |
EBITDA 1 | -0.6482 | -0.7084 | -0.4624 | -1.389 | -2.94 |
EBIT 1 | -0.6726 | -0.7328 | -0.4822 | -1.406 | -2.958 |
Operating Margin | -83.85% | -74.95% | -42.26% | -125.59% | -245.77% |
Earnings before Tax (EBT) 1 | -0.811 | -1.025 | -0.488 | -4.605 | -3.023 |
Net income 1 | -0.811 | -1.025 | -0.488 | -4.605 | -3.023 |
Net margin | -101.11% | -104.79% | -42.77% | -411.43% | -251.22% |
EPS 2 | -1.111 | -1.404 | -0.6685 | -0.1175 | -0.0478 |
Free Cash Flow | - | -0.2837 | 0.0622 | -0.9146 | -1.558 |
FCF margin | - | -29.01% | 5.45% | -81.72% | -129.49% |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 11/10/21 | 11/10/21 | 11/10/21 | 3/28/22 | 3/31/23 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net Debt 1 | 0.65 | 0.89 | 1.24 | - | - |
Net Cash position 1 | - | - | - | 3.14 | 0.24 |
Leverage (Debt/EBITDA) | -1.003 x | -1.262 x | -2.688 x | - | - |
Free Cash Flow | - | -0.28 | 0.06 | -0.91 | -1.56 |
ROE (net income / shareholders' equity) | - | 116% | 40% | -522% | -169% |
ROA (Net income/ Total Assets) | - | -99.8% | -85.9% | -41.6% | -81.4% |
Assets 1 | - | 1.027 | 0.5684 | 11.06 | 3.716 |
Book Value Per Share 2 | -1.000 | -2.340 | -2.950 | 0.0500 | 0.0100 |
Cash Flow per Share 2 | 0.5300 | 0.0700 | 0.1800 | 0.0500 | 0.0100 |
Capex 1 | 0 | 0 | - | 0 | 0 |
Capex / Sales | 0.49% | 0.29% | - | 0.41% | 0.18% |
Announcement Date | 11/10/21 | 11/10/21 | 11/10/21 | 3/28/22 | 3/31/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 694K | |
-5.22% | 265B | |
-5.70% | 91.61B | |
-3.06% | 43.53B | |
+0.85% | 41.33B | |
+5.66% | 39.84B | |
+4.85% | 38.56B | |
-16.24% | 29.91B | |
-7.24% | 28.64B | |
+15.00% | 25.88B |
- Stock Market
- Equities
- PLBL Stock
- Financials Plantable Health Inc.